Financhill
Back

Sonnet BioTherapeutics Holdings Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
42

SONN
Sonnet BioTherapeutics Holdings

Last Price:
$6.22
Seasonality Move:
-20.08%

7 Day Trial

ALL ACCESS PASS

$ 7

Sonnet BioTherapeutics Holdings Stock Forecast

  • Over the next 52 weeks, Sonnet BioTherapeutics Holdings has on average historically fallen by 32.8% based on the past 17 years of stock performance.
  • Sonnet BioTherapeutics Holdings has fallen lower in 15 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 88.24%
  • Is Sonnet BioTherapeutics Holdings Stock Undervalued?
    The current Sonnet BioTherapeutics Holdings [SONN] share price is $6.18. The Score for SONN is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • SONN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Sonnet BioTherapeutics Holdings Stock Go Up Next Year?

  • Over the next 52 weeks, Sonnet BioTherapeutics Holdings has on average historically fallen by 32.8% based on the past 17 years of stock performance.

Sonnet BioTherapeutics Holdings Stock Rating

Sell
42
Sonnet BioTherapeutics Holdings (SONN) is a Sell

Is Sonnet BioTherapeutics Holdings overpriced?

  • Sonnet BioTherapeutics Holdings has fallen lower in 15 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 88.24%

Sonnet BioTherapeutics Holdings Stock Price History

Is SONN stock going to rise?

  • The current trend is moderately bullish and SONN is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sonnetbio.com

52-Week Data

52-Week High:
19.30
52-Week Low:
1.08

Prediction Charts

Market Cap:
19.6M
Price in USD:
6.18
Volume:
1.6M
Beta:
0.64

Technical Analysis

SMA50:
2.40
SMA100:
1.88
SMA200:
2.38
52-Wk Change:
-10.18%

Stock Predictions

  • Is Sonnet BioTherapeutics Holdings stock public?
    Yes, Sonnet BioTherapeutics Holdings is a publicly traded company.
  • What is the Sonnet BioTherapeutics Holdings stock quote today?
    The Sonnet BioTherapeutics Holdings stock price is 6.18 USD today.
  • How to buy Sonnet BioTherapeutics Holdings stock online?
    You can buy Sonnet BioTherapeutics Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-30 1.13 1.25 1.25 1.11
Jul-1 1.23 1.21 1.28 1.21
Jul-2 1.30 4.16 4.40 1.30
Jul-3 3.65 3.92 4.14 3.10
Jul-7 5.74 4.73 6.00 4.54
Jul-8 5.09 4.47 5.66 4.32
Jul-9 4.52 4.64 5.10 4.32
Jul-10 4.61 5.28 5.39 4.19
Jul-11 5.40 5.17 5.67 4.86
Jul-14 15.03 9.64 19.30 7.78
Jul-15 8.32 9.77 10.38 7.63
Jul-16 9.45 8.61 10.34 8.25
Jul-17 8.11 7.79 8.57 7.14
Jul-18 7.51 6.18 7.59 5.90

Sonnet BioTherapeutics Holdings Earnings

Sonnet BioTherapeutics Holdings Earnings Report: Per Share Sonnet BioTherapeutics Holdings Earnings Q1 Q2 Q3 and Q4 last year and next year.

Sonnet BioTherapeutics Holdings Forecast Revenue Growth

Sonnet BioTherapeutics Holdings Stock Analysis: Historical quarterly revenues per share for Sonnet BioTherapeutics Holdings and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $10.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.42 per share, and a decrease next year of $0.00 per share.

* Sonnet BioTherapeutics Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.